financetom
Business
financetom
/
Business
/
UnitedHealth's unit reduces renewal requirements for some prescription drugs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UnitedHealth's unit reduces renewal requirements for some prescription drugs
Mar 19, 2025 5:58 AM

March 19 (Reuters) - UnitedHealth Group's ( UNH )

pharmacy benefit manager, Optum Rx, said on Wednesday it would

ease requirements to get insurance authorization when renewing

prescriptions on about 80 drugs, aiming to reduce the paperwork

for patients and doctors.

The list, which could be expanded over time, will eliminate

up to 25% of these reauthorization requirements and accounts for

more than 10% of all such pharmacy authorizations, it said.

The killing of a UnitedHealth ( UNH ) executive last December had

set off an outpouring of complaints about insurance on social

media, including its and other health insurers' requirements to

seek their approval on medicines.

In January this year, UnitedHealth ( UNH ) said during a conference

call with investors that it would work with policymakers to

reduce the frequency of prior authorizations required before a

patient can access medical treatment in its Medicare business

for people aged 65 and older or with disabilities.

Reauthorizations, or certain checks that patients need to go

through to continue receiving their medications, are necessary

for drugs that have safety concerns, or need ongoing monitoring

for adjusting doses, or additional tests, UnitedHealth's ( UNH ) unit

said.

Newly approved drugs for diseases such as Alzheimer's

require ongoing review, whereas with genetic conditions like

cystic fibrosis, there is minimal additional value in

reauthorizing a treatment, the company said.

Pharmacy benefit managers negotiate drug prices and create

coverage lists for health plans, mainly for employers and the

government. They pay pharmacies directly for prescription drugs

under their agreed terms.

CVS Health's ( CVS ) Caremark, Cigna's ( CI ) Express

Scripts and UnitedHealth's ( UNH ) Optum control the majority of the

U.S. pharmacy benefit market, with their parent companies also

operating health insurance and pharmacy businesses.

They have come under scrutiny for their role in driving up

costs for drugs, and President Donald Trump has also said he

wants to knock out these middlemen.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Suzlon's S144–3 MW wind turbines get big boost from Indian government
Suzlon's S144–3 MW wind turbines get big boost from Indian government
Nov 15, 2023
Th Suzlon wind turbines received the RLMM (Revised List of Models & Manufacturers) listing from the Ministry of New and Renewable Energy, marking an important milestone for the successful commercialisation of the product. Shares of Suzlon Energy Ltd ended at ₹40.49, up by ₹1.85, or 4.79%, on the BSE.
SJVN secures 200-MW wind power project at ₹3.24 per unit
SJVN secures 200-MW wind power project at ₹3.24 per unit
Nov 16, 2023
Projected to generate 482 million units in its inaugural year post-commissioning, the cumulative energy generation over a 25-year span is anticipated to reach 12,050 million units. Shares of SJVN Ltd ended at ₹75.17, down by ₹0.50, or 0.66%, on the BSE.
This sustainable jewellery brand is luring some women away from gold
This sustainable jewellery brand is luring some women away from gold
Oct 30, 2023
Aulerth's offerings range from ₹5,000 to as high as ₹2.8 lakh. Are women willing to spend this much on jewellery made from scrap? Founder and CEO Vivek Ramabhadran definitely believes so. Aulerth produces couture-inspired pieces in association with designers like JJ Valaya, Suneet Varma, among others. It has reported 33% repeat customers in the past year and expects a spike to 40% soon.
Tata Power Renewable Energy wins 200-MW project in collaboration with SJVN
Tata Power Renewable Energy wins 200-MW project in collaboration with SJVN
Nov 28, 2023
The firm and dispatchable renewable energy (FDRE) project, designed with a hybrid of solar, wind, and battery storage, is aimed at providing a stable and dispatchable energy supply during peak hours. Shares of Tata Power Company Ltd ended at ₹270.75, up by ₹12.60, or 4.88%, on the BSE.
Copyright 2023-2026 - www.financetom.com All Rights Reserved